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Abstract
Uropathogenic Escherichia coli (UPEC) are capable of occupying physiologically distinct
intracellular and extracellular niches within the urinary tract. This feat requires the timely
regulation of gene expression and small RNAs (sRNAs) are known to mediate such rapid
adjustments in response to changing environmental cues. This study aimed to uncover
sRNA-mediated gene regulation in the UPEC strain UTI89, during infection of bladder epi-
thelial cells. Hfq is an RNA chaperone known to facilitate and stabilize sRNA and target
mRNA interactions with bacterial cells. The co-immunoprecipitation and high throughput
RNA sequencing of Hfq bound sRNAs performed in this study, revealed distinct sRNA pro-
files in UPEC in the extracellular and intracellular environments. Our findings emphasize
the importance of studying regulatory sRNAs in a biologically relevant niche. This strategy
also led to the discovery of a novel virulence-associated trans-acting sRNA—PapR. Dele-
tion of papR was found to enhance adhesion of UTI89 to both bladder and kidney cell lines
in a manner independent of type-1 fimbriae. We demonstrate PapR mediated posttranscrip-
tional repression of the P-fimbriae phase regulator gene papI and postulate a role for such
regulation in fimbrial cross-talk at the population level in UPEC. Our results further implicate
the Leucine responsive protein (LRP) as a transcriptional activator regulating PapR expres-
sion. Our study reports, for the first time, a role for sRNAs in regulation of P-fimbriae phase
variation and emphasizes the importance of studying pathogenesis-specific sRNAs within a
relevant biological niche.
Author Summary
Recent years have seen an increasing emphasis placed on the role of small RNAs (sRNAs)
in the regulation of bacterial gene expression and stress adaptation. The advent of high-
throughput sequencing methods has now made it possible to directly monitor the appear-
ance of potentially virulence-associated sRNAs that may contribute to rapid adaptation of
the pathogen to a changing environment during infection. Uropathogenic Escherichia coli
PLOS Pathogens | DOI:10.1371/journal.ppat.1005109 August 20, 2015 1 / 23
OPEN ACCESS
Citation: Khandige S, Kronborg T, Uhlin BE, Møller-
Jensen J (2015) sRNA-Mediated Regulation of P-
Fimbriae Phase Variation in Uropathogenic
Escherichia coli. PLoS Pathog 11(8): e1005109.
doi:10.1371/journal.ppat.1005109
Editor: Matthew A Mulvey, University of Utah,
UNITED STATES
Received: January 27, 2014
Accepted: July 24, 2015
Published: August 20, 2015
Copyright: © 2015 Khandige et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Funding: This work was supported by a Mobility Ph.
D. Stipend from the Danish Natural Sciences
Research Council. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
(UPEC) are presumably exposed to a deluge of stimuli from epithelial cell contact, urine
and host immune factors and we asked if any regulatory sRNAs would play a role in the
transition of UPEC from the extracellular niche to the intracellular one. This study
employs co-immunoprecipitation using the RNA chaperone Hfq to identify novel viru-
lence-associated sRNAs in intracellular UPEC, followed by high-throughput RNA-seq.
We report the identification of a novel sRNA that we designate PapR (P-fimbriae regula-
tor) and elaborate on this discovery by demonstrating a role for PapR in regulation of P-
fimbriae—a UPEC surface virulence factor. The results presented in this study offer new
insights into the molecular mechanisms of UPEC pathogenesis and a role for sRNA medi-
ated regulation of virulence factors.
Introduction
Uropathogenic E.coli (UPEC) are a group of genetically heterogeneous isolates [1] known to
display a complex infection cycle within their host. In the course of acute cystitis, UPEC invade
the superficial bladder epithelial cells and replicate in the host cell cytoplasm to form intracellu-
lar bacterial communities (IBCs) consisting of coccoid cells arranged in a biofilm-like structure
[2]. IBCs subsequently mature into motile rod-shaped bacteria and filaments that are fluxed
out of the infected epithelial cell [3, 4]. While a majority of in vivo[3, 5] and in vitro [6] studies
have examined UPEC behaviour in the course of acute urinary bladder infection (cystitis),
UPEC are also capable of causing renal tissue infection (pyelonephritis) with more serious clin-
ical implications. This requires timely expression of bacterial virulence genes relevant to differ-
ent histological niches [7].
UPEC possess an extensive repertoire of secreted virulence factors [8, 9] and surface adhe-
sins that are expressed in a coordinated manner to aid adhesion and invasion of the host epi-
thelium. UPEC isolates are known to encode up to10 fimbrial operons [10] expressing a range
of surface adhesins and the best understood among these are type-1 and P-fimbriae. While a
synergistic relationship may exist between type-1 and P-fimbriated cells at the population level
during ascending urinary tract infection (UTI) [11], it has generally been hypothesized that
UPEC predominantly express type-1 fimbriae during infection of the bladder epithelium [12]
as opposed to expressing P-fimbriae in the renal environment [13]. The pyelonephritis associ-
ated pilus gene cluster, pap, encodes for P-fimbriae that recognize the Gal-α(1–4)β-Gal glyco-
sphingolipid moiety on kidney cells via PapG- the adhesive tip of the fimbria [14].
P-fimbrial expression is subject to phase variation involving a reversible epigenetic switch
between ON and OFF states which responds to regulator proteins encoded within the operon,
PapI and PapB, as well as the global transcription regulators H-NS, cAMP receptor protein
(CRP), DNA adenine methylase (Dam) and Leucine responsive protein (LRP) [15]. There are
two GATC Dam methylation sites, one distal and one proximal to the main operon promoter
(pBA), within the regulatory region intergenic to papI and papB. Reversible binding of LRP
and PapI to either one of the two GATC sites allows for Dam-mediated methylation of the
unbound exposed site, thereby turning pap transcription ON or OFF [16]. Another regulatory
protein, PapB, indirectly facilitates phase switching by activating papI transcription from the
divergent pI promoter [17].
Successful bacterial pathogens efficiently adapt to changing environments inside a host dur-
ing infection. The past few years have seen considerable efforts dedicated towards understand-
ing the survival strategies that intracellular pathogens adopt and the extent to which small
regulatory non-coding RNAs are involved. Small regulatory RNAs (sRNAs), with their short
sRNA-Mediated P-Fimbrial Gene Regulation in UPEC
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half-life, may constitute an efficient means by which pathogens make snap decisions that
favour survival in response to environmental stresses during infection [18, 19]. Recent studies
[20] have revealed a role for sRNAs in the regulation of virulence factors, particularly surface
fimbriae [21, 22], suggesting that rapid sRNA mediated regulation may offer an advantage
even in highly regulated fimbrial operon systems.
The majority of the sRNAs discovered in Gram negative bacteria so far are trans-acting and
exert their function via interaction with Hfq—a homohexameric RNA chaperone protein. Sev-
eral studies have shown Hfq to be important in the scheme of bacterial virulence [23–25], pre-
sumably owing to its role in mediating sRNA-mediated regulation of a wide variety of cellular
pathways important to pathogenesis: biofilm formation [26], motility [27] and epithelial cell
invasion [28]. Scouting for sRNAs expressed by an intracellular pathogen during infection is
fraught with challenges of low RNA yields and although recent years have seen sRNAs consis-
tently reported in the context of infection, few have studied regulation by sRNAs in an intracel-
lular niche [29–31].
This study is based on the premise that the altered transcriptional profile of UPEC during
infection and intracellular survival should also be reflected in its sRNA repertoire. In order to
identify novel pathogenesis-associated sRNAs expressed by intracellular UPEC infecting
human bladder epithelial cells in culture, we adopted an established strategy involving an Hfq-
RNA co-immunoprecipitation (co-IP) approach followed by RNA-seq. This study demon-
strates that the expressed sRNA profile changes substantially in UPEC upon invasion of blad-
der cells and further reports the identification of PapR, a novel pathogen specific sRNA
enriched during infection that plays a role in P-fimbria phase variation.
Results
Deep sequencing of Hfq pull-down RNA from a pathogen reflects its
intracellular environment
This study was aimed at not just obtaining a global snapshot of known Hfq-regulated sRNAs
in the course of UPEC infection but, more specifically, identifying novel sRNAs important in
the scheme of infection. We constructed a triple FLAG-tagged (3xFLAG) version of hfq [32] on
the chromosome of UPEC cystitis strain UTI89 [33], to be used for infection of the human
bladder epithelial cell line—PD07i [34]. Presence of the Hfq 3xFLAG allowed for efficient co-
IP of Hfq and its bound RNA using anti-FLAG monoclonal antibodies. UTI89 expressing Hfq
3xFLAG (UTI89Hfq 3xFLAG) was tested by stationary infection in the bladder cell line and
confirmed to match the efficiency of UTI89 expressing untagged Hfq (referred to as UTI89wt
from here on) in terms of cell adhesion and invasion capacity (Fig 1), thereby validating its
suitability for use in co-IP experiments. The hfq deletion mutant UTI89Δhfq displayed a
reduced ability to adhere to- and invade bladder epithelial cells (Fig 1).
This observation corresponds with other studies showing that Hfq plays a vital role in regula-
tion of virulence-associated genes during infection [35]. Intracellular UTI89Hfq 3xFLAG was
harvested from within infected PD07i cells as well as a parallel culture-grown reference and fur-
ther subjected to Hfq-RNA co-immunoprecipitation and RNA-seq. The distribution and read
coverage of sequenced sRNA species from UTI89 during infection and growth in liquid culture
were found to be substantially different. This difference likely reflected bacterial adaptation to the
intracellular environment. Several known and previously characterized sRNAs were found to be
differentially expressed during infection and those most significant have been illustrated in Fig 2.
Our comparison of the sRNA profiles from culture and infection revealed an increase in the
expression of MicA and RybB, known negative regulators of outer membrane (OM) proteins
[36] in the intracellular compartment along with an observed 2-3-fold decrease in the cDNA
sRNA-Mediated P-Fimbrial Gene Regulation in UPEC
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sequence reads for their respective targets ompA and ompC [37, 38]. DsrA and GcvB were also
among the upregulated sRNAs during infection while McaS, CyaR, Spot42, RyeA, RyeB and
ArcZ were the most down regulated sRNAs during infection. While the overall pattern of
sRNAs expressed in the course of our infection study showed a distinct tendency towards func-
tions in intracellular survival and virulence, this profile is representative of the early stages of
adhesion and invasion of bladder epithelia.
Identification of novel sRNAs in the context of UPEC infection
In order to find novel sRNAs from our high throughput sequencing data we employed SIPHT:
an sRNA prediction software [39], and candidates thus identified were mapped to the UTI89
genome (NC_007946.1) and analyzed further. Among the 15 novel candidates tested from in
silico predictions, two resulted in a stable transcript detectable by Northern blotting and the
novel sRNAs were designated PapR and C271 (Fig 3). While C271 levels were mostly unaltered
between culture and intracellular growth, PapR showed a ~3 fold increase by Northern blotting
(Fig 3A) and close to 6-fold increase in expression in RNA-seq data (Fig 3B) during intracellu-
lar growth.
Unlike C271, PapR was found in a range of extraintestinal pathogenic E. coli (ExPEC)
strains, enterohemorrhagic E. coli (EHEC) and Shigella sp. but not in E. coli K-12 (S1 Fig).
Interestingly, PapR was not found to be conserved in all UPEC strains, further attesting to the
individual genomic variability among UPEC strains that has been reported in the past [1].
Aligned cDNA reads corresponding to both sRNAs were in close agreement to their mapped 5’
termini as confirmed by primer extension (Fig 4A, S2 Fig). Owing to the differential expression
observed during infection, subsequent efforts reported in this study were directed towards the
elucidation of PapR function. MFold RNA secondary structure predictions [40] suggest that
PapR contains a Rho-independent terminator along with AU-rich single-stranded regions,
which could potentially interact with Hfq (S3 Fig).
Northern blot analysis revealed that PapR levels were drastically reduced in UTI89Δhfq (Fig
4B), indicating that the expression or stability of PapR was dependent on functional Hfq.
Fig 1. Hfq impact on bladder cell infection. PD07i bladder cells cultured in 24-well plates were infected with UPEC strains cultured overnight at 37°C in LB
medium. Mean CFU counts of triplicates from three independent experiments were plotted and standard deviation calculated. UTI89Δhfq showed a
statistically significant reduction in adhesion as well as invasion (*p-value <0.05).
doi:10.1371/journal.ppat.1005109.g001
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Fig 2. Differential sRNA expression during infection.Graphical representation of percentage coverage of
normalized sequence reads from culture reference and infection cDNA libraries corresponding to known
sRNAs.
doi:10.1371/journal.ppat.1005109.g002
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Examination of the papR promoter region revealed a partial LRP consensus binding site
composed of flanking CAG/CTG triplets and an intervening AT-rich sequence at ~83 nt
upstream of the mapped transcription start site. We probed UTI89Δlrp for PapR and found
that deletion of lrp abrogated PapR expression, thereby identifying LRP as a transcriptional
activator of PapR expression. The expression of PapR was correspondingly restored to wildtype
levels in the Δlrp and Δhfq complemented strains (Fig 4B and 4C).
PapR regulates the expression of P-fimbria
In order to characterize PapR function, we created a papR deletion strain UTI89ΔpapR and a
low-copy number inducible PapR expression plasmid, pSK1, which allows for complementa-
tion of phenotypes associated with papR deletion. The PA1/O4/O3 promoter driving papR
expression from pSK1 was induced by the addition of 1mM IPTG (isopropyl-β-d-thiogalacto-
pyranoside). We found that deletion of papR did not affect UTI89 growth rate in LB medium
or Epilife cell culture medium (S4 Fig). Using CopraRNA [41], we performed an in silico
mRNA target prediction and found papImRNA to be among the predicted targets of PapR
mediated regulation. Alternative in silico predicted mRNA targets are listed in S1 Table. In an
attempt to further investigate the potential involvement of PapR in regulation of P-fimbrial
biogenesis, agglutination assays with yeast cells and human erythrocytes (RBC) were per-
formed. Bacterial cultures grown statically in liquid media are known to show a propensity
towards expression of type-1 fimbriae and this preference switches to P-fimbriae during
growth on solid surfaces [42]. In light of this, we tested UTI89/pNDM220 (vector control),
UTI89ΔpapR/pNDM220 and UTI89ΔpapR/pSK1 for P-fimbriation in statically grown
Fig 3. Novel sRNAs detected in UTI89. (A) Northern blots showing transcript levels for PapR and C271.
Lanes 1 and 2 represent RNA from culture reference and infection respectively. (B) Graphical output of
normalized sequence reads mapping to PapR and C271 in culture reference and infection visualized using
Integrated Genome Viewer (Broad Institute). The table below includes normalized total read counts within the
PapR and C271 probes.
doi:10.1371/journal.ppat.1005109.g003
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overnight LB cultures so as to enhance any contrasts in agglutination phenotypes between the
UTI89 with and without PapR. While UTI89/pNDM220 displayed mannose sensitive yeast
agglutination, UTI89ΔpapR/pNDM220 displayed mannose resistant agglutination to a small
extent in yeast cells (Fig 5A right) and to a much greater extent in RBCs (Fig 5A left). The man-
nose resistant agglutination phenotype was lost in the complemented strain UTI89ΔpapR/
pSK1 (Fig 5A bottom row), suggesting that PapR negatively regulates expression of a mannose
resistant fimbrial type like P-fimbriae. The role of PapR as a mediator regulating mannose
resistant surface adhesins was subsequently investigated in an in vitro infection assay using
human cell lines derived from the urinary bladder (PD07i) and inner medullary collect ducts of
kidney (IMCD3). Bacterial adhesion to both cell lines was tested with untreated and α-D-man-
nose pre-treated strains in parallel in order to not only estimate the influence of PapR on cell
adhesion but also clearly demonstrate type-1 fimbriae independent adhesion. In concurrence
with our observations from the agglutination assay, UTI89ΔpapR/pNDM220 demonstrated
increased adhesion (p-value<0.05) to bladder and kidney epithelial cells in a mannose resis-
tant manner (Fig 5B). As observed with the agglutination assay previously, this phenotype was
absent in the UTI89ΔpapR/pSK1 complemented strain. While PapR was found to have no sig-
nificant bearing on the pathogen’s ability to invade bladder cells, the IMCD3 kidney cell line
however, demonstrated a clear increase in adhesion as well as invasion when infected with
UTI89ΔpapR (S5 Fig).
The results obtained from agglutination- and adhesion assays indicated that deletion of
papR resulted in an increase in mannose-resistant surface fimbriae such as P-fimbriae, at least
Fig 4. LRPmediated transcriptional activation of PapR. (A) PapR transcriptional start site was mapped
using primer extension reaction loaded in the lane marked 1 alongside Sanger sequencing reactions for the
four nucleotides represented in lanes GCAT. (B) Northern blotting was used to detect PapR levels in UTI89/
pNDM220 (lane 1), UTI89Δlrp/pNDM220 (lane 3) and UTI89Δhfq/pNDM220 (lane 5) with the respective
complemented strains UTI89Δlrp/pSKlrp (lane 2) and UTI89Δhfq/pJMJ220 (lane 4), all cultured in LB
medium. 5S RNA was used as the internal loading control. (C) Illustration of the genomic context of PapR in
the UTI89 genome, drawn to scale. LRP was found to positively regulate papR transcription.
doi:10.1371/journal.ppat.1005109.g004
sRNA-Mediated P-Fimbrial Gene Regulation in UPEC
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Fig 5. Characterization of PapR function. (A) Heme- and yeast cell agglutination assays performed with UTI89/pNDM220, UTI89ΔpapR/pNDM220 and
UTI89ΔpapR/pSK1 with and without the addition of α-D-mannose. Scale bars set at 50 μm. (B) PD07i bladder cells and IMCD3 kidney collecting duct cells
cultured in 24-well plates were infected with UTI89/pNDM220, UTI89ΔpapR/pNDM220, UTI89ΔpapR/pSK1 and UTI89Δhfq. Strains were either left
untreated (-) or treated (+) with 3% α-D-mannose and used for infection. Bacterial adhesion was assessed by calculating mean CFU counts from three
independent experiments. Statistical significance was calculated using Students t-test (*p-value <0.05). (C) Flow cytometry of UTI89/pNDM220,
sRNA-Mediated P-Fimbrial Gene Regulation in UPEC
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at the population level. In order to examine the influence exerted by PapR at the single cell
level, flow cytometric analysis using UTI89 strains immunostained for P- and type-1 fimbriae
was performed. Strains were grown statically overnight in LB medium and immunolabelled in
parallel with either anti-PapA or anti-Fim antibodies, to reveal a mixed population with cells
expressing type-1 as well as cells expressing P-fimbriae on their surface. Fluorescence micros-
copy imaging as well as Western blotting of cultures grown statically overnight in LB medium
was performed to confirm antibody labelling specificity for both anti-PapA and anti-Fim anti-
bodies (S6 Fig). While UTI89/pNDM220, UTI89ΔpapR/pNDM220 and UTI89ΔpapR/pSK1 all
demonstrated simultaneous expression of both P- and type-1 fimbriae at the population level
(Fig 5C); P-fimbriated cells composed a much smaller fraction of the population in both
UTI89/pNDM220 and UTI89ΔpapR/pSK1. Deletion of papR resulted in a doubling of the frac-
tion of P-fimbriated cells (p-value<0.05), whereas in contrast, the fraction of type-1 express-
ing cells appeared to be unaffected by papR deletion.
PapR based repression of P-fimbrial phase variation via papI targeting
The pap gene cluster is present as a single copy in the UTI89 genome [43] unlike some other
UPEC strains, making it a more straightforward subject of study. Expression of the pap gene
cluster is regulated on multiple levels by different but interconnected global regulators along
with two regulatory proteins encoded within the pap gene cluster—PapI and PapB. The regula-
tory genes papI and papB are transcribed from two divergent promoters—pBA and pI. Tran-
scription from the pBA promoter results in a primary transcript which is quickly cleaved by
RNase E into separate papB and papA transcripts which differ in their stability as RNA tran-
scripts [44]. In order to ascertain the in vivo regulatory effect on papImediated by PapR- a reg-
ulatory sRNA located outside the pap-associated pathogenicity island of UTI89, we chose to
adopt a well-established approach using pap-lac operon reporter fusions [16, 45, 46]. We per-
formed β-galactosidase assays by ectopically expressing PapR from pSK1 in E. coli K-12 derived
strains, DL1504 and DL2121 that lack an endogenous pap gene cluster but are genetically mod-
ified to carry a lac operon fusion in the chromosome. Details of DL1504 and DL2121fusion
constructs have been illustrated by Braaten et.al [16] and Nou et.al. [47] respectively. These
strains contain a chromosomal insertion of the entire papI and papB genes with their native
divergent promoters and the intergenic pap regulatory region between them, with a papB-lacZ
operon fusion. In addition, the papB promoter region in the DL2121 strain carries a mutation
in the LRP binding site #3 rendering it independent of PapI mediated phase regulation. We
found that the DL1504 strain with the pNDM220 empty vector showed the same level of β-
galactosidase activity (measured at 17 Miller units) as the parental DL1504 without plasmid
and that upon induction of PapR expression with 1mM IPTG the β-galactosidase activity of
DL1504/pSK1 was reduced by half. These findings were compounded by the lack of any dis-
cernible change in β-galactosidase activity both in DL1504ΔpapI and DL2121 (Fig 6A and 6B),
indicating that regulation of P-fimbriae expression by PapR was more likely to be mediated at
the level of papImRNA. PapI is known to play a role in the phase ON/OFF transition of the
pap operon by regulating the alternation of LRP binding from sites 1, 2, 3(OFF) to sites 4, 5, 6
(ON) [48].
In silico predictions revealed a region of near-perfect complementarity spanning 22 nucleo-
tides in PapR and in papImRNA, including most of the AU rich regions upstream of the PapR
UTI89ΔpapR/pNDM220 and UTI89ΔpapR/pSK1 grown overnight in LB medium and immunolabelled with α-PapA and α-Fim antibodies was used to detect
the extent of P- and type-1 fimbriated cells respectively. Mean fluorescence from three independent experiments was plotted along with the standard
deviations. Statistical significance was calculated using Students t-test (*p-value <0.05).
doi:10.1371/journal.ppat.1005109.g005
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terminator (S3 Fig). The putative region of interaction between papImRNA and papR was pre-
dicted to be 74–96 nucleotides downstream of the papI translation start site and thus was sug-
gestive of PapR regulating papImRNA by means of destabilization of the mRNA [49, 50].
In order to confirm that down regulation of P-fimbriae was mediated through direct base
pairing between PapR and papImRNA, we constructed a plasmid vector pSK1 to express an
altered PapR sRNA (PapR) with an inverted terminator stem region, thus abolishing base
pairing with the target mRNA while ensuring that the PapR sRNA would not suffer secondary
structural perturbations. As a reporter we constructed a papI::gfp translational fusion as devised
previously by Urban and Vogel [51]. Owing to the position of the predicted region of interac-
tion inside the papIORF, the entire length of the gene in addition to a short upstream region at
the 5’ end was cloned into a low copy number vector—pXG10, with a constitutively active λPL
promoter. PapR and PapR sRNAs were expressed from pSK1 and pSK1 respectively using
1mM IPTG induction. These assays were performed in an E.coli K-12 background without
Fig 6. PapRmediated papI repression. (A) β-galactosidase assays were performed with DL1504 strains with and without papI. Induction of PapR using
1mM IPTG resulted in a 50% reduction in β-galactosidase activity in DL1504 (*p-value <0.05) but not DL1504ΔpapI. Mean values from three independent
experiments were plotted and standard deviations calculated. (B) PapR was induced with 1 mM IPTG in DL2121 strains and mean values of β-galactosidase
activity measured in Miller units were plotted. (C) Validation of papI as a PapR target was performed using Top10/pSKpapI/pNDM220 (lane 1), Top10/
pSKpapI/pSK1 (lanes 2–3) and Top10/pSKpapI/pSK1* (lanes 4–5). Strains were grown with (lanes 1, 2 and 4) and without (lanes 3 and 5) the presence of 1
mM IPTG to induce PapR from pSK1 and PapR* from pSK1*. Northern blot detection of PapR, PapR* and papI::gfp levels was carried out in parallel with
Western blot detection of PapI::GFP. GroEL and 5S were used as internal controls in the Western and Northern blots respectively.
doi:10.1371/journal.ppat.1005109.g006
sRNA-Mediated P-Fimbrial Gene Regulation in UPEC
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endogenous pap gene cluster or papR. All transformants were grown aerobically to exponential
phase in LB medium and cultured for an additional 30 mins with or without IPTG, after which
cells were harvested for total RNA isolation for Northern blotting and whole cell lysates for
Western blotting. By detecting RNA levels of papI::gfp and papR in conjunction with protein
levels of PapI::GFP, a composite view of PapR-mediated post-transcriptional repression of
papI could be visualized. Fig 6C shows that PapR and PapR were synthesized at similar levels
upon IPTG induction, but only PapR leads to a reduction in the papI::gfpmRNA level (~3
fold) and GFP protein level (~2 fold). The absence of any PapR-mediated regulation supports
the suggested requirement for a direct base pairing interaction between PapR and its papI
mRNA target.
Discussion
The role played by sRNAs in making rapid cellular decisions and regulating transcription in
pathogenic bacteria, although currently underrepresented in the literature, could be a substan-
tial one [52, 53]. In this study, the uropathogenic E. coli strain UTI89 harvested from within
infected bladder epithelial cells was investigated in order to identify novel virulence-associated
Hfq-interacting sRNAs. We report the discovery of two sRNAs conserved among related
ExPEC strains which were designated PapR and C271.
Bacterial sRNAs are broadly categorized as cis- and trans-encoded regulators of gene expres-
sion. In Gram negative bacteria, a vast majority of trans-encoded sRNAs are known to depend
on Hfq- a global RNA chaperone, for structural stability and regulatory function [54]. Bacterial
sRNAs are known to demonstrate target mRNA repression either by obscuring the ribosome
binding site to prevent translation or by mediating target mRNA degradation. Conversely,
sRNAs are also known to function as translational activators and in both instances, a region of
sequence complementarity is required for this sRNA-mRNA interaction and Hfq enables this
interaction [55, 56].
Overall, our survey of UTI89 sRNA profiles during infection and in vitro culture displayed a
pronounced tendency towards stress adaptation in the intracellular environment. During infec-
tion, UTI89 showed increased expression of sRNAs responding to envelope stress—MicA,
RybB and DsrA. It has been known for some time, that cases of acute UPEC-mediated cystitis
are associated with the development of tightly clustered intracellular bacterial communities
(IBCs) [5] and that IBC development is crucial to the later stages that manifest in the scheme
of UPEC infection [57]. Outer membrane (OM) proteins, particularly OmpA, have been
shown to be critical for IBC maturation later in infection but not essential during the early
stages of adhesion and invasion of bladder epithelia [58]. In this context, MicA and RybB may
facilitate rapid down regulation of OM proteins in the initial phase of infection, only to enable
omp expression when required again during the later IBC stage. DsrA, which was also
increased in infection, is a known positive regulator of RpoS [59]- an alternate sigma factor
vital to stress response that has been implicated in UPEC virulence and intracellular survival in
the urinary bladder [35, 60]. Another positive regulator of RpoS activity [61], GcvB RNA, was
also found to be induced in intracellular UPEC. GcvB is further known to regulate amino acid
metabolism [62], the transcriptional regulator of curli synthesis CsgD [63] and the PhoP/Q
two component system [64]. Interestingly, GcvB is also a known negative regulator of LRP
[65], a transcription factor that we show regulates PapR expression in UTI89. Intracellular
pathogens adopt sRNA mediated regulation as part of a defence strategy that aids survival
inside a hostile host environment as well as an important part of an offensive response the
pathogen mounts against its host [66, 67]. Chao et.al. [68] demonstrated the changing sRNA
profile in an LB culture of Salmonella over time and in doing so, emphasized the dynamic
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nature of sRNA expression and the rapid regulation it mediates. At a single time point, our
sRNA profile during infection is more likely to be a snapshot view of early adaptations to intra-
cellular survival within bladder epithelial cells.
UPEC are known to possess a variety of virulence factors ranging from adhesive fimbriae on
the cell surface to secreted toxins that render them potent pathogens. Fimbrial adhesion to the
host epithelium is an important first step in early infection and some UPEC strains have been
reported to possess as many as ten putative fimbrial operons [69], and of these, type-1 and P-
fimbriae are among the better characterized. Pichon et.al. [20] recently reported several viru-
lence-associated antisense RNAs (asRNA) in the UPEC strain 536 grown in LB medium, one
of which was FimR, a regulator of type-1 fimbriae. Despite the fim operon being highly con-
served across UPEC strains, our RNA-seq data did not reveal read counts corresponding to
FimR. This could in turn reflect back to the fact that our study involved an Hfq co-IP which
might result in a failure to represent asRNAs in the samples since they are less likely to be Hfq
dependent [55]. We suggest that this should be considered as a potential limitation in studies
employing a strategy solely involving Hfq co-IP.
Studies have shown that UPEC infection of the urinary bladder is predominantly associated
with the expression of type-1 fimbriae [70, 71]. However, agglutination of erythrocytes by
UTI89ΔpapR in an α-D-mannose resistant manner and a lack of in silico predicted targets
from the fim operon, decidedly pointed away from any direct role for PapR in expression of
mannose sensitive type-1 fimbriae. Concurrently, by performing parallel adhesion assays
where strains were untreated or treated with α-D-mannose prior to infection, it was possible to
provide clear evidence of mannose resistant surface fimbriae being responsible for the elevated
adhesion observed for UTI89ΔpapR. Infection was carried out in two human cell lines derived
from the urinary bladder and inner medullary collecting ducts of the kidney, representing two
distinct pathological niches UPEC are known to occupy. Although UTI89ΔpapR demonstrated
significantly improved adhesion in both cell lines, this effect was greater in the kidney derived
cell line. The kidney cell line also displayed a significant increase in UTI89ΔpapR invasion
when compared to UTI89/pNDM220, confirming that the nature of surface fimbriae could
influence UPEC tissue tropism. However, this improved adhesion was not followed by a subse-
quent increase in invasion in the bladder derived cell line; a phenomenon that has been previ-
ously reported in relation to P-fimbriae and in vitro infection of bladder epithelial cell lines
[72]. A reduced propensity towards epithelial cell adhesion and invasion was observed for
UTI89Δhfq in accordance with previous reports [35]. It was however interesting to note that α-
D-mannose treatment further debilitated UTI89Δhfq, perhaps indicating that while Hfq does
not influence expression of type-1 fimbriae in UTI89, it could have bearing on alternative viru-
lence factors critical for bladder cell adhesion. Since fim and pap operon deletion mutants were
not included in the infection assays, improved epithelial cell adhesion of UTI89ΔpapR in the
infection assays could not be attributed with certainty to P-fimbriae but rather just to a man-
nose resistant fimbrial type, While the agglutination and adhesion assays provide hints as to
the nature of surface fimbriae expressed at the population level, by fimbriae-specific immuno-
labelling and flow cytometry we were able to examine single cells to demonstrate a greater frac-
tion of P-fimbriated cells in the PapR null mutant when compared to UTI89wt. Our findings
with flow cytometry revealed the presence of both type-1 fimbriated and P-fimbriated bacteria
in the population. This could indicate that decisions favouring one type of surface adhesin over
another could be made on a population scale, by elevating synthesis of mediators like PapR
that would tip the scales in favour of a particular adhesin: type-1 fimbriae [11, 73]. The expres-
sion of a particular fimbrial variant is dependent on the tissue niche UPEC occupy and studies
have shown that expression of type-1 fimbriae is favoured during infection of bladder epithelial
cells since they are more rigid and resistant to urine flow [74] and expression of P-fimbriae is
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favoured when the pathogen ascends to the renal pelvis and infects the kidney [13]. Our obser-
vation that mean fluorescence did not significantly vary across strains labelled with α-PapA
antibody, further supports the idea that PapR expression is more likely to alter the ratio of P-
fimbriated cells in the population rather than the extent of P-fimbriation on an individual cell.
This could indicate that there might be selective expression of PapR within population sub-
groups in response to as yet unknown environmental cues.
Despite previous reports suggesting minimal involvement of P-fimbriae in UPEC infections
[13], Buckles et.al. [75] recently showed that P-fimbriae fulfil Koch’s postulates as a bona fide
virulence factor and form part of the pathogenesis repertoire even in UPEC strains causing
acute cystitis. While the precise advantage conferred by P-fimbriae to UPEC in the course of
infection is still unclear, P-fimbriae have been purported to aid ascension of the pathogen from
the bladder and establishment of infection in the kidney [75, 76] as well as function as an
immunomodulant influencing the immune responses within a local niche [77–79].
Pathogens are able to rapidly perceive environmental cues and correspondingly modulate
their choice of surface adhesins by a means of phase variation, which is essentially believed to
be an immune evasion strategy as well as an adaptive response to boost the odds of bacterial
survival in the face of a changing environment [80]. Especially in pathogenic bacteria, ON/OFF
phase variation of surface adhesins could be key to expressing the best suited adhesin for the
target tissue, in a sequential manner [81]. The presence of an LRP consensus sequence
upstream of the PapR transcription start site along with the abrogation of papR transcription
in an lrp null mutant identifies LRP as a transcriptional activator of PapR synthesis. This find-
ing adds an additional layer of complexity and implies a dual role for LRP in P-fimbriae phase
switching under the conditions when bacteria are localized in host cells. A summarizing model
illustrating the roles we now have identified for PapR and Lrp in modulation of P-fimbriae
phase variation is shown in Fig 7. LRP is a global regulator known to directly influence both
type 1 and P-fimbriae phase variation in E.coli. Regulation of PapR could represent an addi-
tional indirect means of LRP involvement in type 1and P-fimbrial crosstalk.
Apart from the global regulators cAMP-CAP, H-NS, Dam methylase and LRP, the pap
operon is regulated by proteins encoded within the gene cluster, PapI and PapB. PapI is known
to be involved in ON/OFF phase transition of P-fimbria by interacting with the pap DNA-LRP
complex [82, 83]. This PapI interaction results in translocation of the complex occupying LRP
binding sites #1–3 and blocking pBA transcription, to LRP binding sites #4–6, resulting in acti-
vation of the pBA promoter. Results ensuing from the β-galactosidase assays using strains with
a functional papI (DL1504), papI null strain (DL1504ΔpapI) and papI independent expression
system (DL2121), all indicated that PapR targeted papImRNA and thereby regulated P-fim-
brial phase variation. A GFP reporter system was used to not only confirm direct interaction
between PapR and its target papImRNA, but also to identify the region of interaction by
employing the pSK1 plasmid construct with an inverted terminal stem loop region. The lack
of any reduction in the levels of papI::gfpmRNA as a consequence of PapR expression from
pSK1 plasmid, confirms the in silico predicted region of interaction to hold true.
PapR overall expression levels being two fold higher during infection than in the culture
grown reference condition, could reflect a need to support type-1 fimbriae expression (prefera-
ble during bladder cell invasion) while simultaneously repressing P-fimbriae expression, when
infecting bladder epithelial cells. Owing to early experimental evidence suggesting involvement
of PapR in P-fimbrial regulation, no alternative mRNA targets from in silico predictions were
explored in this study. This however, does not preclude the possibility that PapR might well act
on multiple fronts in UPEC.
PapR sRNA represents a new principal addition to the repertoire of macromolecules
involved in pap regulation, presumably promoting the advantage of a rapid ON/OFF switch
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favouring the best-suited surface adhesin at the time within at least part of the population, and
thereby enhancing the odds of the pathogen’s survival within its specific tissue niche. A few
recent studies have reported sRNA-mediated regulation of surface fimbriae in pathogenic bac-
teria [20, 84] further substantiating our hypothesis regarding the value of sRNA mediated
modulation of gene expression even in an already heavily regulated system.
Fig 7. Model illustrating PapR-mediated modulation of P-fimbriae phase variation. The pap gene cluster encodes two regulatory proteins, PapI and
PapB, that work in concert with other global regulators such as LRP, H-NS and Dammethylase to control P-fimbrial phase variation between the OFF and
ON states. LRPmediated transcriptional activation of PapR sRNA results in the degradation of papImRNA. An absence of functional PapI results in a failure
to switch from an OFF to an ON phase, and a failure therein to express P-fimbriae on the surface.
doi:10.1371/journal.ppat.1005109.g007
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Survival of a pathogen and success in infection, hinges on its ability to efficiently sense signals
from the host environment and make suitable adaptations [85] including a modulation of its
own surface in accordance with the surrounding niche. In this work we took advantage of high
throughput sequencing technology that allows analyses of low input starting material in order
to explore pathogen behaviour in its biologically relevant niche. There has been a growing role
attributed to sRNAs in the context of bacterial pathogenesis as a versatile regulatory device in
control of bacterial virulence strategies. This study revealed that intracellular pathogens express
their own unique sRNAs as part of their infection armament. The discovery of PapR, and C271
specifically in pathogenic E. coli and their expression in the context of infection, should prompt
additional efforts to clarify the complete sRNA repertoire that such pathogens possess.
Materials and Methods
Bacterial strains and growth conditions
A cystitis-derived isolate E. coli UTI89 with serotype O18:K1:H7 was used for RNA sequencing
and strain constructions (S2 Table). E. coli K-12 derived DL1504 and DL2121 were used for β-
galactosidase assays and Top10 was used for validation of sRNA target interaction. UTI89 har-
vested for RNA-seq was obtained from infection and culture reference involving overnight
lysogeny broth (LB) culture followed by 3 hours of static growth at 37° C in Epilife cell culture
media to replicate infection conditions. Strains for other experiments were grown in LB broth
supplemented with 100 μg/ml ampicillin, 40 μg/ml chloramphenicol (Cml) and 40 μg/ml kana-
mycin (Kan) as required. Expression was induced from the PA1/O4/O3 promoter with 1 mM iso-
propyl-β-d-thiogalactopyranoside (IPTG).
The deletion strains UTI89Δhfq, UTI89ΔpapR and UTI89Δlrp were made using pKD3/
pKD4 plasmid templates to amplify Cml and Kan resistance cassettes respectively as described
by Datsenko and Wanner [86]. Insertion of Cml cassette was confirmed using primers JMJ99
and JMJ100 and Kan cassette using primers JMJ71 and JMJ72. UTI89Hfq 3xFLAG was con-
structed using primers JMJ155 and JMJ156 and pSUB11 plasmid template as detailed by Uzzau
et.al.[32]. Plasmid pSK1 (JMJ835+JMJ836), pSK1 (JMJ835+JMJ645) and pSKlrp (JMJ939+-
JMJ940) were derived by cloning native PapR, PapR with an inverted terminator stem region
and lrp respectively into the pNDM220 vector as described by Boysen et.al.[87] and constructs
were confirmed using JMJ207+JMJ221. Plasmid pSKpapI was derived from pXG-10 plasmid
using plasmids JMJ641+JMJ642 to construct a papI::gfp translational fusion and confirmed
using JMJ732+JMJ733. All relevant primer pairs are listed in S3 Table.
Stationary infection
PD07i bladder epithelial cells kindly provided by David Klumpp [34] were cultured and main-
tained in Epilife medium supplemented with human keratinocyte growth serum (Invitrogen) as
described previously [6]. Human kidney derived inner medullary collecting duct IMCD3 cells
were generously donated by Per Svenningsen and cultured in DMEM:F12 nutrient mix cell cul-
ture media (Life Technologies) supplemented with 10% FBS. PD07i and IMCD3 cells were
seeded in 24-well plates and infected at 80–90% confluency. An MOI of 100 bacteria was used
and infection was carried out for 2 hours, followed by an hour of treatment with 100 μg/ml gen-
tamicin. The fraction of bacteria adhering to the epithelial cell surface was procured prior to
gentamicin treatment by performing three washes with PBS, followed by addition of 500μl of
0.25% trypsin-EDTA and 1% triton X-100 each. Bacterial cell suspensions thus obtained were
suitably diluted in PBS and plated on LB agar for CFU counts. Similarly, the intracellular bacte-
rial counts from within PD07i and IMCD3 were obtained post gentamicin treatment and suit-
able dilutions of bacterial suspensions were plated on LB agar for CFU counts.
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Hfq co-IP and RNA-seq data analysis
UTI89Hfq 3xFLAG cultured overnight in LB medium was used to infect PD07i bladder epithe-
lial cells and harvested 3hrs post infection. In parallel, UTI89Hfq 3xFLAG cultured overnight
in LB medium was grown statically in Epilife cell culture medium and maintained at 37°C and
5% CO2 for the duration of infection to serve as the reference condition. 10
8 bacterial cells were
harvested in IP buffer (10 mM Tris pH 7.5, 150 mM KCl, 1 mMMgCl2, Protease inhibitor and
Ambion AntiRNAse) and lysed by French press. Cell lysate was incubated with 100 μl of M2
paramagnetic anti-FLAG agarose beads (Sigma) that had been pre-washed twice in IP buffer,
for 4 hours at 4°C. Beads were washed twice with cold IP buffer and phenol-chloroform extrac-
tion of RNA was performed. Downstream processing of purified co-IP RNA was performed
and sequencing was carried out on an Illumina HiSeq2000 platform by Vertis Biotechnology
(Munich, Germany).
The quality of raw cDNA reads was examined using FastQ and barcodes clipped. Sequence
reads (50 nt) were mapped to UTI89 genome (NC_007946.1) and visualized using the Inte-
grated Genome Viewer (Broad Institute). Read counts were calculated using SeqMonk (Babra-
ham Bioinformatics) by normalizing for total reads mapping to the genome in each cDNA
library and gene length. Exact duplicate reads were rejected and gene-wise quantitation was
performed by counting the number of reads with a minimum of 10 nt overlap to gene annota-
tions. SIPHT [39] programme was used to predict candidate sRNAs within the UTI89 genome
and these predictions were compared to RNA-seq data to find novel candidate sRNAs.
Agglutination assays
Cultures were grown statically overnight in LB at 37°C. A 10 mg/ml suspension of bakers’ yeast
in PBS was freshly prepared for yeast agglutination and fresh 8% erythrocyte suspension from
type A- whole blood was used for hemagglutination. Equal volumes of the overnight bacterial
culture was mixed with the yeast/erythrocyte suspensions on a glass slide and observed for visi-
ble agglutination with and without addition of freshly prepared 3% α-D-mannose.
Northern blotting and primer extension
Total RNA was isolated using heavy phase lock gel tubes (5Prime) and Northern blot analysis
of papR (JMJ834), C271 (JMJ767) and 5S was performed as described previously [88]. Samples
were electrophoresed along with a RiboRuler low range RNA ladder (Thermo Scientific) and
transferred onto Zeta-probe membranes (Bio-Rad). Membranes probed with radiolabelled
primers were visualized using a Typhoon FLA9500 scanner (GE Healthcare) and bands quanti-
fied where appropriate using Image Studio Lite Version 4.0 software. Primer extension analysis
was carried out as described by Franch et al.[89] using primers JMJ832+JMJ833 to amplify
PapR with upstream and downstream flanking regions by PCR to serve as template for the
sequencing reaction and radiolabelled JMJ834 was used in both sequencing and reverse tran-
scription reactions. Relevant primers are listed in S3 Table.
Western blotting
~108 bacteria were harvested from appropriate cultures by spinning down cells equivalent to
OD600 = 1. Bacterial pellets were then resuspended in 1× SDS loading buffer (60 mm Tris-HCl,
pH 6.8, 2% SDS, 10% glycerol, 0.005% bromophenol blue, 5 mm EDTA, 0.1 m DTT), boiled
for 5 min and separated on a 4–12% Invitrogen NuPage novex Bis-Tris mini gels as detailed by
Boysen et.al [87]. The proteins transferred onto PVDF membranes (Amersham Hybond) were
hybridized with 1:20000 dilution of primary anti-GFP (Roche), 1:2000 anti-Fim, 1:1000 anti-
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PapA and a loading control of 1:50000 dilutions of primary anti-GroEL as appropriate. 1:2000
dilutions of appropriate secondary antibodies (Dako, Denmark) were used in the SNAP i.d.2.0
blotting system (Millipore). Chemiluminescent visualization of protein bands was performed
using the Thermo Scientific Pierce ECLWestern Blotting Substrate according to the manufac-
turer’s instructions.
Flow cytometry and immunofluorescence microscopy
Specimens for flow cytometry and immunofluorescence microscopy were fixed with 3.7% para-
formaldehyde for 10 min. and washed gently with PBS three times. 2% BSA for 10 min. was
used to block nonspecific signals after which samples were washed once with PBS and stored at
4°C overnight. Bacterial strains were stained with 1:500 anti-Fim [90] and 1:500 anti-PapA fol-
lowed by 1:200 secondary antibody anti-rabbit conjugated with Alexafluor488 for 1 hour each.
All solutions were prepared fresh on the day. Anti-Fim and anti-PapA primary polyclonal anti-
bodies were generated against the entire extracellular type 1 fimbrial filament and PapA respec-
tively. Flow cytometry was performed on a BD FACSAria II flow cytometer (Becton,
Dickinson and Company). Data from 105 events per sample was collected and analyzed using
BD FACSDiva software (Becton, Dickinson and Company). Strains were distinguished first on
the basis of forward scatter area (FSC-A) and side scatter area (SSC-A) and second on the basis
of forward scatter area (FSC-A) and FITC fluorescence area (FITC-A). Microscopy was per-
formed using a Leica DMRE fluorescence microscope. Image contrast and addition of scale
bars were performed using ImageJ software.
β-galactosidase activity measurement
Bacteria were resuspended in PBS at appropriate concentrations and 100 μl was used along
with 900 μl of Z-buffer (1 M Na2CO3, 0.27% β-mercaptoethanol) for each replicate in the
assay. Samples were incubated with 4 mg/ml ONPG (ortho-Nitrophenyl-β-galactoside) to
allow development of yellow colour and reactions were terminated with addition of 1 M
Na2CO3. Optical density was measured at wavelengths of 550 nm and 420 nm and Miller units
calculated.
Statistical analysis
All infection, β-galactosidase assays and flow cytometry experiments were conducted using
biological triplicates and mean values and standard deviations were calculated and plotted. Stu-
dent’s t-test was used to calculate p-values and determine statistical significance using Graph-
Pad Prism 5.01 software. P-values of less than 0.05 were defined as significant for all
experiments.
Accession number
The RNA-seq data has been deposited in the EBI-ArrayExpress database, Accession number
E-MTAB-3498.
Supporting Information
S1 Fig. PapR and C271 sequence conservation.Multiple sequence alignment of (A) PapR and
(B) C271 sRNAs showed a high level of sequence and secondary structure conservation among
related Gram-negative strains. Alignments were generated using LocARNA software tool [91],
complementary base pairs are coloured red and the hue represents sequence conservation.
(TIF)
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S2 Fig. Mapping C271 to the UTI89 genome. (A) Primer extension was performed to map
transcription start site of C271 alongside Sanger sequencing reactions to be read from left to
right as TACG. (B) Illustration of the genomic context of C271 in UTI89, drawn to scale.
(TIF)
S3 Fig. PapR secondary structure. In silico secondary structure prediction of PapR sRNA
using Mfold software. The predicted region of interaction between PapR and papImRNA is
illustrated in red extending over a single stranded region and the terminal stem-loop. The
nucleotide bases in the terminal stem that were inverted in the modified PapR are denoted by
an asterisk ().
(TIF)
S4 Fig. Growth curves. UTI89/pNDM220, UTI89ΔpapR/pNDM220 and UTI89ΔpapR/pSK1
were grown at 37°C in aerated LB medium (−) and Epilife cell culture medium (). Optical
density was measured at 600 nm wavelength at 60 min intervals and plotted against time in
hours. Mean OD600 from three independent experiments along with their standard deviations
was plotted.
(TIF)
S5 Fig. Invasion assay. PD07i bladder cells (grey) and IMCD3 kidney medullary collecting
duct cells (red) cultured in 24-well plates were infected with UTI89/pNDM220, UTI89ΔpapR/
pNDM220, UTI89ΔpapR/pSK1 and UTI89Δhfq for 2 h followed by 1 h of gentamycin treat-
ment to kill extracellular bacteria. Strains were either treated (+) or left untreated (-) with 3%
α-D-mannose. Bacterial invasion was assessed by calculating mean CFU counts from three
independent experiments and p-value ( <0.05) calculated by t-test.
(TIF)
S6 Fig. Immunofluorescence imaging and western blotting of fimbriae. UTI89wt stained
with anti-Fim (A) and anti-PapA (B) antibodies were examined by immunofluorescence
microscopy to demonstrate staining specificity. The panels on the left represent anti-Fim (Ai)
and anti-PapA (Bi) fluorescence images and the panels to the right (Aii and Bii) represent the
corresponding phase contrast images. Red arrowheads mark unstained UTI89wt and black
arrowheads mark UTI89wt cells that stain positive for the particular fimbriae. Scale bars set at
10 μm. Western blots show single bands corresponding to Fim (Aiii) and PapA (Biii). GroEL
was used as the internal loading control.
(TIF)
S1 Table. Alternate mRNA target predictions for PapR and C271 sRNAs generated using
CopRNA (Freiburg RNA tools suite) [41].
(PDF)
S2 Table. List of strains used in the study.
(PDF)
S3 Table. Primers used in this study.
(PDF)
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